LES ACTIVITÉS NUCLÉAIRES : RAYONNEMENTS IONISANTS ET RISQUES POUR LA SANTÉ ET L’ENVIRONNEMENT 1.6.3 – ASNR’s other technical support organisations To diversify its expertise and benefit from other particular skills, ASNR in 2025 committed credits of about €211,000 and paid €186,000. As a result, ASNR was able to finance the expert assessments needed to analyse the OEF from the construction of the Flamanville EPR reactor from the point of view of human and organisational factors, in order to identify areas of oversight for the EPR 2 reactors, and the expert assessment of the non-radiological risk sections of the safety reports for the 900 MWe reactors at Chinon. It has also funded the drafting of operational documents aimed at establishing a voluntary professional qualification for radon expertise in buildings, as well as the establishment of an inventory of practices concerning the performance of radiological examinations carried out without medical indication. 1.7 The pluralistic working groups ASNR has set up several pluralistic working groups; they enable the stakeholders to take part in developing doctrines, defining action plans or monitoring their implementation. 1.7.1 – The working group on the National Radioactive Material and Waste Management Plan Article L. 542-1-2 of the Environment Code requires the drafting of a National Radioactive Material and Waste Management Plan (PNGMDR), which is revised every five years and serves to review the existing management procedures for radioactive materials and waste, to identify the foreseeable needs for storage and disposal facilities, specify the necessary capacity of these facilities and the storage durations and, for radioactive waste for which there is as yet no final management solution, determine the objectives to be met. The Working Group (WG) tasked with drafting the PNGMDR notably comprises environmental protection associations, experts, representatives from industry and regulatory authorities, alongside the radioactive waste producers and managers. Also known as the “Technical Commission”, it is co-chaired by the General Directorate for Energy and Climate of the Ministry of Energy Transition and ASNR. This WG is part of the governance system for the PNGMDR, which also comprises a “Guidance Committee” whose role is to inform the Ministry regarding the strategic implications of the Plan and in which ASNR is a participant. Chapter 13 presents the PNGMDR and its governance system in greater detail. 1.7.2 – The Steering Committee for Managing the Nuclear Post-Accident Phase Pursuant to an Interministerial Directive of 7 April 2005 on the action of the public authorities in the case of an event leading to a radiological emergency situation, ASNR, together with the ministerial departments concerned, is tasked with defining, preparing for and implementing the necessary measures to manage a post-accident situation. Under a mandate from the Prime Minister's office, ASNR has, since 2005, regularly brought together all the players involved in the Steering Committee for managing the Nuclear Post-Accident Phase (Codirpa) in order to improve the doctrine drawn up in 2012 and updated in 2022, taking into account the work of thematic working groups and the OEF from national and international exercises. This Committee, headed by ASNR, has representatives from the ministerial departments concerned, the health agencies, associations, and CLI representatives. The work of the Codirpa is presented in greater detail in chapter 4. 1.7.3 – The Committee for the Analysis of New Techniques and Practices using Ionising Radiation The Committee for the Analysis of New Techniques and Practices using Ionising Radiation (Canpri) was created on 8 July 2019. This Committee is chaired by ASNR and comprises 13 experts from professional organisations, appointed by ASNR, along with representatives of the French health institutions (National Authority for Health – HAS, National Cancer Institute – INCa, Ministry of Health, National Agency for the Safety of Medicines and Health Product – ANSM) and the administration (General Directorate for Health – DGS, General Directorate for Healthcare Organisation – DGOS). Canpri's aim is to identify new techniques and practices in the medical field, analyse their radiation protection implications and to produce recommendations and conclusions regarding patient and worker radiation protection. Its work has led it to issue an opinion on the conditions for setting up the ZAP-X gyroscopic radiosurgery platform in France, in 2023, and another opinion, in 2025, on the development of FLASH radiotherapy. For more details on these subjects refer to point 1.3.2 of chapter 5. 1.7.4 – The other pluralistic working groups In 2012, ASN set up the Steering Committee for Social, Organisational and Human Factors (Cofsoh) in order to advance the deliberations and work on the contribution of individuals and organisations to the safety of nuclear installations and worker protection. In addition to ASNR, it includes institutional representatives, environmental protection associations, individuals chosen for their scientific, technical, economic or social expertise, nuclear activity managers (in particular licences of nuclear facilities), professional federations in the nuclear sector and representative employee trade unions. Today, Cofsoh serves as a forum for promoting and sharing the work carried out in the field of human and organisational factors, structuring its discussions around annual thematic cycles. ASNR also leads the national committee responsible for overseeing the national radon risk management Plan. In 2019 and 2020, the committee drew up the 4th radon plan for the period 2020-2024, which was published in early 2021 (see chapter 3). The Committee met six times for this purpose. As part of this Plan, since 2018 ASNR has been leading a working group responsible for coordinating communication actions on radon risk management. 1.8 The other stakeholders In the context of its missions to protect the general public from the health risks of ionising radiation, ASNR cooperates closely with other institutional stakeholders with competence for health issues. 1.8.1 – National Agency for the Safety of Medicines and Health Products The National Agency for the Safety of Medicines and Health Products (ANSM) was set up on 1 May 2012. The ANSM, a public institution reporting to the Ministry in charge of health, has taken over the functions of the AFSSAPS (French Health Products Safety Agency) 136 ASNR Report on the state of nuclear safety and radiation protection in France in 2025
RkJQdWJsaXNoZXIy NjQ0NzU=